![](/img/cover-not-exists.png)
Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial
Brahmer, Julie R, Rodríguez-Abreu, Delvys, Robinson, Andrew G, Hui, Rina, Csőszi, Tibor, Fülöp, Andrea, Gottfried, Maya, Peled, Nir, Tafreshi, Ali, Cuffe, Sinead, O'Brien, Mary, Rao, Suman, Hotta, KatLanguage:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(17)30690-3
Date:
November, 2017
File:
PDF, 442 KB
english, 2017